Loading...
Loading...
India's potassium imports from UNITED STATES total $903.9K across 369 shipments from 15 foreign suppliers. ACTAVIS LABORATORIES FL INC leads with $536.7K in import value; the top 5 suppliers together control 72.3% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for potassium — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ACTAVIS LABORATORIES FL INC is the leading Potassium supplier from UNITED STATES to India, with import value of $536.7K across 4 shipments. The top 5 suppliers — ACTAVIS LABORATORIES FL INC, ACTAVIS LABORATORIES FL INC., ESPEE BIOPHARMA & FINECHEM LLC, NEW LIFE MEDICALS LLC.., BAXTER HEALTHCARE CORPORATION — collectively account for 72.3% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS LABORATORIES FL INC | $536.7K | 4 | 59.4% |
| 2 | ACTAVIS LABORATORIES FL INC. | $41.3K | 40 | 4.6% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $30.0K | 19 | 3.3% |
| 4 | NEW LIFE MEDICALS LLC.. | $24.5K | 2 | 2.7% |
| 5 | BAXTER HEALTHCARE CORPORATION | $20.9K | 3 | 2.3% |
| 6 | SPRING BIO SOLUTION | $18.4K | 5 | 2.0% |
| 7 | AMNEAL PHARMACEUTICALS OF LLC | $14.0K | 6 | 1.5% |
| 8 | AGRACE PHARMA | $13.8K | 14 | 1.5% |
| 9 | AMSTERDAM PHARMA (APTEKA RX INC) | $10.9K | 11 | 1.2% |
| 10 | PHARMACEUTICAL BUYERS, INC | $10.4K | 3 | 1.2% |
| 11 | RAFF&HALL PHARMACY | $10.3K | 1 | 1.1% |
| 12 | SUTPHIN DRUGS INC | $9.7K | 2 | 1.1% |
| 13 | CLINIGEN INC | $9.4K | 3 | 1.0% |
| 14 | RAFF & HALL PHARMACY, | $9.1K | 2 | 1.0% |
| 15 | AMNEAL LLC | $7.7K | 21 | 0.9% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $572.7K | 40 | 63.4% |
| 2 | CIPLA LIMITED | $35.7K | 6 | 3.9% |
| 3 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $25.1K | 33 | 2.8% |
| 4 | UMEDICA LABORATORIES PRIVATE LIMITED | $24.5K | 2 | 2.7% |
| 5 | ARAGEN LIFE SCIENCES LIMITED | $20.9K | 3 | 2.3% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $12.7K | 6 | 1.4% |
| 7 | HETERO LABS LIMITED | $11.3K | 15 | 1.3% |
| 8 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $10.8K | 6 | 1.2% |
| 9 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $10.4K | 5 | 1.2% |
| 10 | ZYDUS LIFESCIENCES LIMITED | $10.3K | 19 | 1.1% |
| 11 | LAURUS LABS LTD | $9.9K | 3 | 1.1% |
| 12 | ALKEM LABORATORIES LIMITED | $9.9K | 5 | 1.1% |
| 13 | AUROBINDO PHARMA LTD | $9.3K | 16 | 1.0% |
| 14 | LAURUS LABS LIMITED | $7.7K | 19 | 0.8% |
| 15 | GLENMARK PHARMACEUTICALS LIMITED | $7.5K | 5 | 0.8% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Potassium suppliers from UNITED STATES to India include ACTAVIS LABORATORIES FL INC, ACTAVIS LABORATORIES FL INC., ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is ACTAVIS LABORATORIES FL INC with import value of $536.7K USD across 4 shipments. India imported Potassium worth $903.9K USD from UNITED STATES in total across 369 shipments.
India imported Potassium worth $903.9K USD from UNITED STATES across 369 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Potassium sourced from UNITED STATES include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, CIPLA LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $572.7K in imports across 40 shipments.
The total value of Potassium imports from UNITED STATES to India is $903.9K USD, across 369 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
369 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists